Goldman Sachs Group »

Cardiol Therapeutics Inc- foreign shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $20k 24k 0.84
2023-09-30 $21k 24k 0.90
2023-06-30 $21k 24k 0.89
2023-03-31 $12k 25k 0.49
2022-12-31 $52k 102k 0.51
2022-03-31 $100k 66k 1.52
2021-12-31 $233k 126k 1.85
2021-09-30 $79k 19k 4.14